ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

Hemophilia and Rare Bleeding Disorders » Acquired Hemorrhagic Coagulation Disorders

Theme Navigation

  • ISTH 2022 Congress
    • Hemophilia and Rare Bleeding Disorders
      • Acquired Hemorrhagic Coagulation Disorders

Abstract Number: PO0029

Acquired Hemophilia A: case report

A. Sarmento1, C. Almeida1, M. Mendes2, L. Borges2

Abstract Number: PB0168

Acquired Hemophilia in four north European countries, a survey of 181 patients

R. Lindahl1, A. Leithinen2, V. Nummi3, T. Szanto4, L. Hiltunen5, A. Olsson6, A. Glenthoej7, R. Chaireti8, I. Vaide9, E. Funding10, E. Zetterberg11

Abstract Number: PB1431

Acquired von Willebrand syndrome in essential thrombocythemia patients referred to special coagulation laboratory of Iranian Blood Transfusion Organization (IBTO)

A. Rajabi1, M. Ahmadinejad2, S. Ebrahimi3, M. Mojtabavi Naeini4, S. Riahi4, R. Shamriz4, P. Eshghi

Abstract Number: VPB0170

Correlation of Factor VIII Activity Measured by One-Stage Clotting and Chromogenic Substrate Assays in a Phase III Study of Emicizumab Prophylaxis for Acquired Hemophilia A (AGEHA)

K. Yoneyama1, K. Tokuda2, R. Ozaki1, R. Kobayashi1, Y. Oguchi1, A. Kiialainen3, K. Amano4, M. Shima5

Abstract Number: OC 63.5

Cytokine profile of patients with Acquired Hemophilia A (AHA) in a longitudinal study

J. Frade-Guanaes1, A. Racanelli1, L. Siqueira1, C. Costa-Lima1, S. Medina1, N. Foschi1, L. De Lima1, A. Francisco1, M. Colella1, S. Montalvão2, G. Yamaguti-Hayakawa1, M. Ozelo1

Abstract Number: OC 40.2

Efficacy, Safety, and Pharmacokinetics of Emicizumab Prophylaxis in Patients with Acquired Hemophilia A: Primary Analysis Results from a Phase III Study (AGEHA)

M. Shima1, K. Amano2, Y. Ogawa3, K. Yoneyama4, R. Ozaki4, R. Kobayashi4, E. Sakaida5, M. Saito6, T. Okamura7, T. Ito8, N. Hattori9, S. Higasa10, N. Suzuki11, Y. Seki12, K. Nogami1

Abstract Number: PB0167

Emicizumab use in Acquired von Willebrand Disease: Single Case Report

M. Escobar1, I. Aboshady2, N. Montanez2

Abstract Number: PB0166

Five cases of Acquired Haemophilia A (AHA) following COVID-19 vaccination in Australia

C. Dix1, B. Reardon2, J. Curnow2, R. Bird3, S. P'ng4, H. Tran5

Abstract Number: PB0169

Proof of principle of a fast and fully automated FVIII functional inhibitor test

B. Verbruggen1, N. Binder2, G. Moore3, R. Polenewen4

Abstract Number: PO0028

Report of clinical case: Acquired hemophilia with a high-titer inhibitor and hemorrhagic diathesis.

R. Santoja Rubio1, A. Tugues2, E. Vicente2, C. Marzo3, P. Monteagudo4, L. Amuh4, C. Chávez5, M. Teixidó4, A. Garcia5, A. Luaña4, A. Ferrero4, A. Ruiz5, T. Garcia4

« View all themes from the ISTH 2022 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley